[The effect of dalargin on the course of combined radiation lesions (experimental research)].
Legeza
V I
VI
Zhiliaev
E G
EG
Koshcheev
A G
AG
Konovalova
L I
LI
D000818:Animals; D004353:Drug Evaluation, Preclinical; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D009104:Multiple Trauma / Q000188:drug therapy* / Q000473:pathology; D009336:Necrosis; D011817:Rabbits; D011833:Radiation Injuries, Experimental / Q000188:drug therapy* / Q000473:pathology; D013997:Time Factors; D014945:Wound Healing / Q000187:drug effects; D014948:Wounds, Gunshot / Q000188:drug therapy* / Q000473:pathology
D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Vliianie dalargina na techenie kombinirovannykh radiatsionnykh porazheniĭ (éksperimental'noe issledovanie).